Fig. 3: Forest plot of progression-free survival and overall survival in the subgroup-stratified full analysis set. | Nature Communications

Fig. 3: Forest plot of progression-free survival and overall survival in the subgroup-stratified full analysis set.

From: Sintilimab and anlotinib with gemcitabine plus cisplatin in advanced biliary tract cancer: SAGC a randomized phase 2 trial

Fig. 3: Forest plot of progression-free survival and overall survival in the subgroup-stratified full analysis set.The alternative text for this image may have been generated using AI.

A Progression-free survival. B Overall survival. Abbreviations: CI confidence interval, ECOG Eastern Cooperative Oncology Group, ECC extrahepatic cholangiocarcinoma, GBC gallbladder carcinoma;ICC intrahepatic cholangiocarcinoma, SAGC sintilimab plus anlotinib combined with gemcitabine and cisplatin, GC gemcitabine plus cisplatin.

Back to article page